{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:23:40Z","timestamp":1787747020077,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56002-w","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:14:51Z","timestamp":1781244891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world and computational identification of herbal candidates associated with adverse event patterns in glucagon-like peptide-1 therapy for obesity"],"prefix":"10.1038","volume":"16","author":[{"given":"Junkyu","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaiwha","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeongkil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"56002_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(25)00397-6","volume":"405","author":"JA Kerr","year":"2025","unstructured":"Kerr, J. A. et al. Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990\u20132021, with forecasts to 2050: A forecasting study for the Global Burden of Disease Study 2021. The Lancet 405, 785\u2013812 (2025).","journal-title":"The Lancet"},{"key":"56002_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","volume":"9","author":"Z Zheng","year":"2024","unstructured":"Zheng, Z. et al. Glucagon-like peptide-1 receptor: Mechanisms and advances in therapy. Signal Transduct. Target. Ther. 9, 234 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"56002_CR3","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso, S. P. et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375, 1834\u20131844 (2016).","journal-title":"N. Engl. J. Med."},{"key":"56002_CR4","doi-asserted-by":"publisher","first-page":"1535134","DOI":"10.3389\/fcvm.2025.1535134","volume":"12","author":"Y Turkistani","year":"2025","unstructured":"Turkistani, Y. Glucagon-like peptide-1 receptor agonists: A review from a cardiovascular perspective. Front. Cardiovasc. Med. 12, 1535134 (2025).","journal-title":"Front. Cardiovasc. Med."},{"key":"56002_CR5","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/oby.24360","volume":"33","author":"B Sinha","year":"2025","unstructured":"Sinha, B. & Ghosal, S. Efficacy and safety of GLP-1 receptor agonists, dual agonists, and retatrutide for weight loss in adults with overweight or obesity: A Bayesian NMA. Obesity 33, 2046\u20132054. https:\/\/doi.org\/10.1002\/oby.24360 (2025).","journal-title":"Obesity"},{"key":"56002_CR6","doi-asserted-by":"publisher","first-page":"1557691","DOI":"10.3389\/fphar.2025.1557691","volume":"16","author":"C Tao","year":"2025","unstructured":"Tao, C. et al. Glucagon-like peptide-1 receptor agonist-induced cholecystitis and cholelithiasis: A real-world pharmacovigilance analysis using the FAERS database. Front. Pharmacol. 16, 1557691 (2025).","journal-title":"Front. Pharmacol."},{"key":"56002_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3949\/ccjm.92a.24113","volume":"92","author":"AE Mehta","year":"2025","unstructured":"Mehta, A. E., Lomeli, L. D. & Pantalone, K. M. Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce. Clevel. Clin. J. Med. 92, 483\u2013489 (2025).","journal-title":"Clevel. Clin. J. Med."},{"key":"56002_CR8","doi-asserted-by":"publisher","unstructured":"Poluzzi, E., Raschi, E., Piccinni, C. & De Ponti, F. Data mining techniques in pharmacovigilance: Analysis of the publicly accessible FDA Adverse Event Reporting System (AERS). in Data Mining Applications in Engineering and Medicine (ed. Karahoca, A.) (IntechOpen, 2012). https:\/\/doi.org\/10.5772\/50095","DOI":"10.5772\/50095"},{"key":"56002_CR9","volume-title":"American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists","author":"GP Joshi","year":"2023","unstructured":"Joshi, G. P. et al. American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists (American Society of Anesthesiologists, 2023)."},{"key":"56002_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/1574884708666131111205736","volume":"9","author":"F Dabaghzadeh","year":"2014","unstructured":"Dabaghzadeh, F., Khalili, H. & Dashti-Khavidaki, S. Ginger for prevention or treatment of drug-induced nausea and vomiting. Curr. Clin. Pharmacol. 9, 387\u2013394 (2014).","journal-title":"Curr. Clin. Pharmacol."},{"key":"56002_CR11","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00228-025-03849-z","volume":"81","author":"RR Galigutta","year":"2025","unstructured":"Galigutta, R. R. et al. Signal detection of ferric carboxymaltose-induced serious adverse events: Disproportionality analysis of FAERS and VigiBase data and systematic review of case reports. Eur J Clin Pharmacol 81, 1081\u20131096. https:\/\/doi.org\/10.1007\/s00228-025-03849-z (2025).","journal-title":"Eur J Clin Pharmacol"},{"key":"56002_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00228-025-03872-0","volume":"81","author":"T Xia","year":"2025","unstructured":"Xia, T., Shu, B., Peng, Y. & Wang, B. Post-marketing safety signals of imatinib: Pharmacovigilance insights from the FDA Adverse Event Reporting System (FAERS) and implications for clinical practice. Eur J Clin Pharmacol 81, 1343\u20131353. https:\/\/doi.org\/10.1007\/s00228-025-03872-0 (2025).","journal-title":"Eur J Clin Pharmacol"},{"key":"56002_CR13","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00228-025-03900-z","volume":"81","author":"RH Woods","year":"2025","unstructured":"Woods, R. H. Meningioma in users of progestogen contraceptives: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS). Eur. J. Clin. Pharmacol. 81, 1659\u20131668. https:\/\/doi.org\/10.1007\/s00228-025-03900-z (2025).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"56002_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-025-04914-x","volume":"25","author":"P Cordero-P\u00e9rez","year":"2025","unstructured":"Cordero-P\u00e9rez, P. et al. Antioxidant and hepatoprotective effect of Jatropha dioica against the valproic acid-induced damage in an in vivo model. BMC Complement. Med. Ther. 25, 207. https:\/\/doi.org\/10.1186\/s12906-025-04914-x (2025).","journal-title":"BMC Complement. Med. Ther."},{"key":"56002_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12906-024-04676-y","volume":"24","author":"P Tangpradubkiat","year":"2024","unstructured":"Tangpradubkiat, P. et al. Gardenia jasminoides extract mitigates acetaminophen-induced liver damage in mice. BMC Complement. Med. Ther. 24, 371. https:\/\/doi.org\/10.1186\/s12906-024-04676-y (2024).","journal-title":"BMC Complement. Med. Ther."},{"key":"56002_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm, E. et al. The Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. J. Clin. Epidemiol. 61, 344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008 (2008).","journal-title":"J. Clin. Epidemiol."},{"key":"56002_CR17","doi-asserted-by":"publisher","first-page":"18063","DOI":"10.1038\/s41598-025-01206-9","volume":"15","author":"H Chen","year":"2025","unstructured":"Chen, H. et al. Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA adverse event reporting system. Sci. Rep. 15, 18063 (2025).","journal-title":"Sci. Rep."},{"key":"56002_CR18","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"56002_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biosystems.2014.11.005","volume":"127","author":"Y Tang","year":"2015","unstructured":"Tang, Y., Li, M., Wang, J., Pan, Y. & Wu, F.-X. CytoNCA: A Cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems 127, 67\u201372 (2015).","journal-title":"Biosystems"},{"key":"56002_CR20","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge, S. X., Jung, D. & Yao, R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2628\u20132629 (2020).","journal-title":"Bioinformatics"},{"key":"56002_CR21","doi-asserted-by":"publisher","first-page":"D1556","DOI":"10.1093\/nar\/gkaf1095","volume":"54","author":"Z Yu","year":"2026","unstructured":"Yu, Z. et al. PersADE: A database of personalized adverse drug events and their underlying molecular mechanisms. Nucleic Acids Res. 54, D1556-d1568. https:\/\/doi.org\/10.1093\/nar\/gkaf1095 (2026).","journal-title":"Nucleic Acids Res."},{"key":"56002_CR22","doi-asserted-by":"publisher","first-page":"1043789","DOI":"10.3389\/fendo.2022.1043789","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu, L., Chen, J., Wang, L., Chen, C. & Chen, L. Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database. Front. Endocrinol. 13, 1043789 (2022).","journal-title":"Front. Endocrinol."},{"key":"56002_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/oby.23622","volume":"31","author":"GE White","year":"2023","unstructured":"White, G. E. et al. Real\u2010world weight\u2010loss effectiveness of glucagon\u2010like peptide\u20101 agonists among patients with type 2 diabetes: A retrospective cohort study. Obesity 31, 537\u2013544 (2023).","journal-title":"Obesity"},{"key":"56002_CR24","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3390\/ph16070994","volume":"16","author":"S Chiappini","year":"2023","unstructured":"Chiappini, S. et al. Is there a risk for semaglutide misuse? Focus on the food and drug administration\u2019s FDA adverse events reporting system (FAERS) pharmacovigilance dataset. Pharmaceuticals 16, 994 (2023).","journal-title":"Pharmaceuticals"},{"key":"56002_CR25","doi-asserted-by":"publisher","first-page":"975880","DOI":"10.3389\/fphar.2023.975880","volume":"14","author":"X Tan","year":"2023","unstructured":"Tan, X. et al. Glucagon-like peptide-1 receptor agonists as add-on therapy to insulin for type 1 diabetes mellitus. Front. Pharmacol. 14, 975880 (2023).","journal-title":"Front. Pharmacol."},{"key":"56002_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","volume":"7","author":"SL Kristensen","year":"2019","unstructured":"Kristensen, S. L. et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 7, 776\u2013785 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"56002_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/dom.12926","volume":"19","author":"M Monami","year":"2017","unstructured":"Monami, M. et al. Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials. Diabetes Obes. Metab. 19, 1233\u20131241 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"56002_CR28","doi-asserted-by":"publisher","first-page":"721135","DOI":"10.3389\/fendo.2021.721135","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao, X. et al. GLP-1 receptor agonists: Beyond their pancreatic effects. Front. Endocrinol. 12, 721135 (2021).","journal-title":"Front. Endocrinol."},{"key":"56002_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12301","author":"R Ryder","year":"2013","unstructured":"Ryder, R. The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits. Diabet. Med. https:\/\/doi.org\/10.1111\/dme.12301 (2013).","journal-title":"Diabet. Med."},{"key":"56002_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrneph.2017.123","volume":"13","author":"MH Muskiet","year":"2017","unstructured":"Muskiet, M. H. et al. GLP-1 and the kidney: From physiology to pharmacology and outcomes in diabetes. Nat. Rev. Nephrol. 13, 605\u2013628 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"56002_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/ijlh.12830","volume":"40","author":"M Levi","year":"2018","unstructured":"Levi, M. Pathogenesis and diagnosis of disseminated intravascular coagulation. Int. J. Lab. Hematol. 40, 15\u201320 (2018).","journal-title":"Int. J. Lab. Hematol."},{"key":"56002_CR32","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","volume":"385","author":"JP Fr\u00edas","year":"2021","unstructured":"Fr\u00edas, J. P. et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N. Engl. J. Med. 385, 503\u2013515 (2021).","journal-title":"N. Engl. J. Med."},{"key":"56002_CR33","unstructured":"Wang, X. et al. Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 1243\u20131253."},{"key":"56002_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40649-019-0069-y","volume":"6","author":"S Zhang","year":"2019","unstructured":"Zhang, S., Tong, H., Xu, J. & Maciejewski, R. Graph convolutional networks: A comprehensive review. Comput. Soc. Netw. 6, 1\u201323 (2019).","journal-title":"Comput. Soc. Netw."},{"key":"56002_CR35","doi-asserted-by":"publisher","first-page":"111845","DOI":"10.1016\/j.jep.2019.111845","volume":"238","author":"SM Dehghani","year":"2019","unstructured":"Dehghani, S. M., Bahroloolomifard, M. S., Yousefi, G., Pasdaran, A. & Hamedi, A. A randomized controlled double blinded trial to evaluate efficacy of oral administration of black strap molasses (sugarcane extract) in comparison with polyethylene glycol on pediatric functional constipation. J. Ethnopharmacol. 238, 111845 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"56002_CR36","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ptr.5586","volume":"30","author":"MH Chen","year":"2016","unstructured":"Chen, M. H., May, B. H., Zhou, I. W., Zhang, A. L. & Xue, C. C. Integrative medicine for relief of nausea and vomiting in the treatment of colorectal cancer using oxaliplatin\u2010based chemotherapy: A systematic review and meta\u2010analysis. Phytother. Res. 30, 741\u2013753 (2016).","journal-title":"Phytother. Res."},{"key":"56002_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.phymed.2009.12.016","volume":"17","author":"MW Saif","year":"2010","unstructured":"Saif, M. W. et al. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies. Phytomedicine 17, 161\u2013169 (2010).","journal-title":"Phytomedicine"},{"key":"56002_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3325\/cmj.2025.66.204","volume":"66","author":"J Tar\u010dukovi\u0107","year":"2025","unstructured":"Tar\u010dukovi\u0107, J. et al. The effects of honey solution on postoperative stress, gastric motility, and patient comfort: A randomized controlled trial. Croat. Med. J. 66, 204 (2025).","journal-title":"Croat. Med. J."},{"key":"56002_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/acm.2020.0468","volume":"27","author":"A Ameri","year":"2021","unstructured":"Ameri, A. et al. Effect of honey\u2013lemon spray versus benzydamine hydrochloride spray on radiation-induced acute oral mucositis in head and neck cancer patients: A pilot, randomized, double-blind, active-controlled clinical trial. J. Altern. Complement. Med. 27, 255\u2013262 (2021).","journal-title":"J. Altern. Complement. Med."},{"key":"56002_CR40","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.ijrobp.2016.11.022","volume":"97","author":"SE Fogh","year":"2017","unstructured":"Fogh, S. E. et al. A randomized phase 2 trial of prophylactic manuka honey for the reduction of chemoradiation therapy\u2013induced esophagitis during the treatment of lung cancer: Results of NRG oncology RTOG 1012. Int. J. Radiat. Oncol. Biol. Phys. 97, 786\u2013796 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"56002_CR41","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/AOG.0000000000001898","volume":"129","author":"A Ciardulli","year":"2017","unstructured":"Ciardulli, A., Saccone, G., Anastasio, H. & Bergbella, V. Less-restrictive food intake during labor in low-risk singleton pregnancies: A systematic review and meta-analysis. Obstet. Gynecol. 129, 473\u2013480 (2017).","journal-title":"Obstet. Gynecol."},{"key":"56002_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12906-025-05048-w","volume":"25","author":"S-D Kim","year":"2025","unstructured":"Kim, S.-D. et al. Herbal medicine evaluation for reimbursement-based facial palsy (HERB-FP): A retrospective analysis using Korean health insurance claim data 2020\u20132024. BMC Complement. Med. Ther. 25, 307 (2025).","journal-title":"BMC Complement. Med. Ther."},{"key":"56002_CR43","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/ph17111490","volume":"17","author":"HJ Woerdenbag","year":"2024","unstructured":"Woerdenbag, H. J. et al. Analysis of adverse reactions associated with the use of Crataegus-containing herbal products. Pharmaceuticals 17, 1490 (2024).","journal-title":"Pharmaceuticals"},{"key":"56002_CR44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/ph15080991","volume":"15","author":"H Boucetta","year":"2022","unstructured":"Boucetta, H. et al. Pharmacovigilance of herb-drug interactions: A pharmacokinetic study on the combined administration of tripterygium glycosides tablets and leflunomide tablets in rats by LC-MS\/MS. Pharmaceuticals 15, 991 (2022).","journal-title":"Pharmaceuticals"},{"key":"56002_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejps.2017.07.034","volume":"109","author":"G Li","year":"2017","unstructured":"Li, G. et al. Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents. Eur. J. Pharm. Sci. 109, 182\u2013190. https:\/\/doi.org\/10.1016\/j.ejps.2017.07.034 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"56002_CR46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.phymed.2010.05.003","volume":"17","author":"X Wang","year":"2010","unstructured":"Wang, X., Cheung, C. M., Lee, W. Y., Or, P. M. & Yeung, J. H. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Phytomedicine 17, 868\u2013875. https:\/\/doi.org\/10.1016\/j.phymed.2010.05.003 (2010).","journal-title":"Phytomedicine"},{"key":"56002_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3109\/03602532.2013.815200","volume":"45","author":"M Unger","year":"2013","unstructured":"Unger, M. Pharmacokinetic drug interactions involving Ginkgo biloba. Drug Metab. Rev. 45, 353\u2013385. https:\/\/doi.org\/10.3109\/03602532.2013.815200 (2013).","journal-title":"Drug Metab. Rev."},{"key":"56002_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1045309","volume":"14","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Evaluation of mulberry leaves\u2019 hypoglycemic properties and hypoglycemic mechanisms. Front. Pharmacol. 14, 1045309. https:\/\/doi.org\/10.3389\/fphar.2023.1045309 (2023).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56002-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56002-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56002-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:03:29Z","timestamp":1787745809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56002-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56002"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56002-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study used publicly available, de-identified data.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26780"}}